SeraGene Therapeutics

Thank you to everyone who attended today's announcement! It was wonderful to share this exciting news in person. A special thank you to Minister Brenda Bailey for sharing her vision of how this new Innovation Centre will impact the Vancouver life sciences ecosystem. We also appreciate Marco Ciufolini for discussing NanoVation Therapeutics™'s experience as a current adMare Vancouver resident company. Finally, thank you to Erika Siren for emceeing the event and providing SeraGene Therapeutics's perspective on being part of the Vancouver Innovation Centre. Check out the photos from the event and the tour of the lab space under construction. 👷 We are looking forward to sharing more updates as this project progresses! --- Merci à tous ceux qui ont assisté à l'annonce d'aujourd'hui ! C'était merveilleux de partager cette belle nouvelle en personne. Nous remercions tout particulièrement la ministre Brenda Bailey d'avoir partagé sa vision de l'impact que ce nouveau Centre d'innovation aura sur l'écosystème des sciences de la vie de Vancouver. Nous remercions également Marco Ciufolini d'avoir discuté de l'expérience de NanoVation Therapeutics™ Therapeutics en tant qu'entreprise résidente d'adMare à Vancouver. Enfin, nous remercions Erika Siren d'avoir animé l'événement et d'avoir donné le point de vue de SeraGene Therapeutics sur sa présence au Centre d'innovation de Vancouver. Découvrez les photos de l'événement et la visite de l'espace de laboratoire en construction. 👷 Nous sommes impatients de partager d'autres mises à jour au fur et à mesure que ce projet progresse ! Gordon McCauley (He/Him), Matthew Carlyle, CFA, ICD.D, Dominic Vachon, Lynn McEachern

🚨We are delighted to announce that five new ventures have joined the adMare National Tx Accelerator. We would like to welcome: 🚀9Bio, a biotech company based in Quebec City, QC, focusing on the development of immuno-oncology therapeutics 🚀RejuvenRx, an emerging biotech company located in Montreal, QC, aiming to develop new therapeutics for aging and cancers that focus on stem cell biology. 🚀TATUM bioscience, a therapeutics company based in Sherbrooke, QC, concentrating on developing a new type of immunotherapy for cancer treatment. 🚀SeraGene Therapeutics, a biotech company located in Vancouver, BC, that focuses on developing low-treatment-burden RNA-based therapies for a broad range of blood coagulation disorders. 🚀VeracityBio, a biotech company located in Vancouver, BC, focused on developing technologies that aim to automate and expand traditional methods for evaluating the credibility of research and target-disease associations. adMare is proud to accompany these innovative Canadian companies in their growth, with the aim of advancing life sciences and improving the lives of patients across the nation. Read the announcement ➡️ https://lnkd.in/gQt_4RJ8 --- 🚨 Nous sommes ravis d'annoncer les cinq nouvelles entreprises rejoignant l'Accélérateur national Tx adMare. Nous souhaitons la bienvenue dans l'Accélérateur à : 🚀9Bio, une entreprise de biotechnologie située dans la ville de Québec qui se spécialise dans la mise au point de traitements en immuno-oncologie. 🚀RejuvenRx, une société de biotechnologie émergente basée à Montréal au Québec dont l’objectif est de développer de nouvelles thérapies axées sur la biologie des cellules souches pour lutter contre le vieillissement et les cancers. 🚀TATUM bioscience, une start-up implantée à Sherbrooke au Québec qui développe un nouveau type d’immunothérapie en cancérologie. 🚀SeraGene Therapeutics, une entreprise de biotechnologie située à Vancouver en Colombie-Britannique qui se concentre sur le développement de thérapies à base d’ARN présentant une faible charge thérapeutique pour un large éventail de troubles de la coagulation sanguine. 🚀VeracityBio, une entreprise de biotechnologie située à Vancouver en Colombie-Britannique qui développe des technologies visant à automatiser et à étendre les méthodes traditionnelles d’évaluation de la crédibilité de la recherche et des associations « cible-maladie ». adMare est fière d'accompagner ces entreprises canadiennes innovantes dans leur croissance afin de faire progresser les sciences de la vie et d'améliorer la qualité de vie des patients à travers le pays. Lisez l'annonce ➡️ https://lnkd.in/g35X2sfk

Last April at the Bloom Burton & Co. conference in Toronto, Nancy Harrison and Ali Tehrani of Amplitude Ventures pulled me aside for what they said was an important conversation. There’s something special going on in Vancouver's life sciences sector and you need to write about it, they said. I had already noted many of Canada’s most prominent life sciences companies – like AbCellera, Xenon Pharmaceuticals Inc. , STEMCELL Technologies, Acuitas Therapeutics and Aspect Biosystems – were all based in Canada’s west coast capital and wondered what was behind that. I told them I was interested to know more, and they helped put me in touch with a slew of people representing a cross-section of the local sector. That November I came to Vancouver and spent four marathon days meeting with founders, funders, academics, industry and government representatives and administrators including Wendy Hurlburt, Lana Janes, Ph.D., Carl Hansen, Pieter Cullis, Dermot Kelleher Tom Madden, Ali Ardakani Bill Hunter, Megan Levings, Jerel Davis, Peter Zandstra, Natalie Dakers, Fiona Dalton, Sriram Subramaniam and others. I interviewed about 50 people in total including BC innovation minister Brenda Bailey I also saw some cool science too, including tiny brain “organoids” grown in petri dishes at Stemcell, a giant electron microscope at the service of Dr. Subramaniam on the The University of British Columbia campus, a production facility at Clarius Mobile Health that manufactured handheld, wireless ultrasound readers and a 3D printing machine at Aspect that made synthetic, transplantable tissue. I concluded that Nancy and Ali were right. Sharing with you here the cover story that came out of this. It's about what has made Vancouver this country's most exciting and advanced biotech capital, and how leading players are determined to transform the city – and by turn Canada – into a haven for homegrown pharma giants. It’s about time; we’ve never had one. Canadians discovered insulin a century ago and we’ve made many breakthrough discoveries since, but that science ultimately gets commercialized elsewhere, creating major economic spinoff benefits outside Canada. At a time when Canada's woeful productivity performance is under heightened scrutiny, it’s noteworthy to see an innovative local sector’s players working with such determination and unity. If they succeed – and there is a long way to go – in putting together the missing pieces for a full-stack ecosystem, perhaps they can build a thriving, vertically integrated industry that would bring jobs & prosperity to the region. They are following a roadmap that should serve as a guide to others across Canada. But it’s early days. And Vancouver has been here before; things didn't end well the 1st time. Gordon McCauley (He/Him) adMare BioInnovations, Abdera Therapeutics Francois Benard Angus Livingstone BC Children's Hospital, Vancouver Martha Piper Karimah Es Sabar Andrew Booth Chrystia Freeland François-Philippe Champagne

At the BIOTECanada Investment Summit each year, adMare BioInnovations has the privilege of inviting four early-stage Canadian biotech companies to showcase their innovative work to a panel of life sciences investors and industry leaders in the Emerging Companies Forum.  This invaluable opportunity allows these companies to receive expert advice and feedback on their business models, strategies, and presentations. Discover this year's presenting companies:  ⭐9Bio ⭐Paradox Immunotherapeutics  ⭐RejuvenRx   ⭐SeraGene Therapeutics --- Chaque année, lors du Sommet de l'investissement BIOTECanada, adMare BioInnovations a le privilège d'inviter quatre entreprises canadiennes de biotechnologie en en phase de développement à présenter leurs travaux novateurs à un groupe d'investisseurs en sciences de la vie et de chefs de file de l'industrie dans le cadre du Forum des entreprises émergentes.  Cette occasion inestimable permet à ces entreprises de recevoir des conseils d'experts et des commentaires sur leurs modèles d'affaires, leurs stratégies et leurs présentations. Découvrez les entreprises qui se présentent cette année :  ⭐9Bio  ⭐Paradox Immunotherapeutics  ⭐RejuvenRx   ⭐SeraGene Therapeutics Frederic Lemaitre Auger